HYFT News
MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows
MindWalk Holdings Corp. (MindWalk) (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd (Teva Australia) to deploy ReefIQ, MindWalks HYFT-powered biological context layer with specified LensAI analytical capabilities, in support...
Business Wire
MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows
MindWalk Holdings Corp. (MindWalk) (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd (Teva Australia) to deploy ReefIQ, MindWalks HYFT-powered biological context layer with specified LensAI analytical capabilities, in support...
Business Wire
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that Thomas Lynch, PhD, has departed the company and ceased to serve as Chief Business Officer, effective October 16, 2026. "We thank Thomas for his contributions to MindWalk and wish him well," said...
Business Wire
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its LensAI immunogenicity screening ran across an entire public antibody database of 890,634 sequences in 4 hours and 41 minutes on Amazon EC2 Hpc8a instances powered by 5th Gen...
Business Wire
MindWalk Holdings Corp. (NASDAQ: HYFT) (MindWalk or the Company), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Companys pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director...
Business Wire
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today outlined why the ontology layer now being built across enterprise AI does not reach biological function, and why life sciences requires a biological context layer of its own. ReefIQ, MindWalk's biological context...
Business Wire
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment AI Drug Discovery Forecasts Vary Widely as Sector Shifts to DeploymentPR NewswireAUSTIN, Texas, Oct. 1, 2026Equity Insider News CommentaryAUSTIN, Texas, Oct. 1, 2026 /PRNewswire/ --Towards Healthcare projects that the global AI...
PR Newswire
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced the appointment of Kim Remizowski to its Board of Directors as an independent director, effective September 29, 2026. Mr. Remizowski will serve on the Audit Committee and the Compensation, Nomination and...
Business Wire
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced results from a production deployment of the open-source OpenFold3 structure prediction model, run with engineering partners AMD and Vultr on Vultr Kubernetes Engine and Vultr Cloud GPU powered by AMD...
Business Wire
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -80.00% and -15.48%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
On Monday, MindWalk Holdings (NASDAQ:HYFT) discussed first-quarter financial results during its earnings call. The full transcript is provided below.
This transcript is brought to you by Benzinga APIs. For real-timeread more...
Benzinga